Signant Health develops new program to work more closely with CROs

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)

Related tags: Signant Health, CRO, eclinical

Signant Health’s new partner program was established to help reduce scope creep and prevent miscommunication between CROs and sponsors, says VP.

According to the company – formerly CRF Bracket​ – the new Signant Health Partner Program marks ‘a significant investment’ and the aim is to enable clinical research organizations (CROs) ‘to better serve sponsors,’ specifically as it pertains to patient data, patient experience, clinical supplies, and endpoint quality solutions.

“We are investing in people and streamlined processes to support CRO partners, such as increased training, scientific input, bid defense support, and ongoing governance of relationship,"​ explained Ken Billard, vice president of business development, Signant Health.

Billard added that the program was developed to strengthen the company’s CRO partnerships “to ultimately benefit sponsors.”  

Program partners will receive exclusive commercial terms, business development support, joint marketing, product training, and dedicated resources for governance, according to the company.

“Our goal is to work more closely with CROs to provide strategic planning, scientific insight, bid defense support, and comprehensive training on the Signant Health patient-centered eClinical platform to ensure our joint proposals are appropriately scoped and as comprehensive, scientifically sound, and efficient as possible,” ​Billard told us.

“By defining best practices with CROs covering the proposal process and ongoing delivery of services, we believe we can prevent miscommunication and reduce scope creep that is common when vendors work together,”​ he added.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Related suppliers

Follow us

Products

View more

Webinars